SupportSave Solutions Experiencing Increased Demand for Services
In a significant development, SupportSave Solutions, a provider of Business Process Outsourcing (BPO) services in the Philippines, has reported increased demand for its services, with its financial results for the quarter ended November 30, 2007, showing a significant jump compared to the previous quarter. Meanwhile, other companies such as Monsanto, BioMarin Pharmaceutical, and SIRIUS Satellite Radio have made notable announcements in the tech and business sectors. The overall economic landscape is uncertain, with inflation jitters remaining high due to rising oil prices.
Key Takeaways:
- SupportSave Solutions, a BPO provider in the Philippines, has seen increased demand for its services, with its financial results for the quarter ended November 30, 2007, showing a significant jump compared to the previous quarter.
- Monsanto Company has reported significant progress in its biotech R&D pipeline, with 10 specific projects advancing to the next phase or being added to the pipeline.
- BioMarin Pharmaceutical Inc. and Genzyme Corporation have announced a restructuring of their joint venture regarding Aldurazyme (laronidase), with no significant changes to operational responsibilities.
- SIRIUS Satellite Radio has ended 2007 with a record-high subscriber base of 8,321,785, an increase of 38% from the previous year.
- The ADP report has indicated that the economy added 40,000 private sector jobs in December, exceeding the forecast of economists.
- InvestSource, Inc. has been compensated with 50,000 restricted shares of SupportSave Solutions, Inc. shares for services rendered.
Statistics:
- SIRIUS Satellite Radio ended 2007 with 8,321,785 subscribers, a 38% increase from the previous year.
- The economy added 40,000 private sector jobs in December, according to the ADP report.
- SupportSave Solutions' financial results for the quarter ended November 30, 2007, showed a significant jump compared to the previous quarter.
- Monsanto reported 10 specific projects in its biotech R&D pipeline advancing to the next phase or being added to the pipeline.
- BioMarin Pharmaceutical Inc. and Genzyme Corporation's joint venture has no significant changes to operational responsibilities.
Sources:
- M2 PressWIRE - "SupportSave Solutions Experiencing Increased Demand for Services" - http://biz.yahoo.com/bw/080103/20080103005746.html
- Monsanto Company - "Year of Firsts in Research-and-Development Advances" - http://biz.yahoo.com/prnews/080103/aqth045.html
- BioMarin Pharmaceutical Inc. and Genzyme Corporation - "Restructuring of Joint Venture Regarding Aldurazyme" - http://biz.yahoo.com/prnews/080103/aqth046.html
- SIRIUS Satellite Radio - "Company Ends 2007 with Record-High Subscriber Base" - http://biz.yahoo.com/prnews/080103/aqth047.html
- ADP Report - "Economy Adds 40,000 Private Sector Jobs in December" - http://biz.yahoo.com/bw/080103/20080103005800.html
- InvestSource, Inc. - http://www.investsourceinc.com